Key Details
Price
$94.13Last Dividend
$5.00TTM Dividend Yield
5.31%Annual ROE
28.41%Beta
0.39Events Calendar
Next earnings date:
Feb 10, 2025Recent quarterly earnings:
Oct 30, 2024Recent annual earnings:
Feb 14, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
Nov 18, 2024Next split:
N/ARecent split:
June 21, 2018Analyst ratings
Recent major analysts updates
Screeners with ACGL included
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
Arch Capital Group (ACGL) closed at $95.51 on the most recent trading day, showing a decrease of 0.61% from its previous closing price.
At the end of the last trading day, Arch Capital Group (ACGL) was priced at $90.83, which represents a 0.73% increase compared to the day before.
The recent drop in Arch Capital Group Ltd.'s share price offers a chance to buy, thanks to its solid fundamentals and strong growth in the insurance sector. The company is a leader in property and casualty insurance and reinsurance, with a diverse business model and careful risk management that results in strong profits. Additionally, Arch's recent purchase of Allianz's U.S. commercial middle market and entertainment division boosts its diversification and size, even though there are some risks involved in merging the two businesses.
In the latest trading session, Arch Capital Group (ACGL) finished at $91.38, showing a decrease of 1.05% compared to the day before.
In the latest trading session, Arch Capital Group (ACGL) finished at $91.38, showing a decrease of 1.05% compared to the day before.
ACGL is set for growth due to new business opportunities, greater exposure, improved renewal rates, and efficient use of capital.
In the most recent trading session, Arch Capital Group (ACGL) finished at $92.93, which is an increase of 0.28% compared to the previous day.
On the most recent trading day, Arch Capital Group (ACGL) closed at $88.99, which is an increase of 0.32% compared to its last closing price.
ACGL is benefiting from new business opportunities, rising rates, growth in current accounts, and a strong financial position.
In October, Seeking Alpha welcomed 42 new analysts who brought a variety of investment ideas and strategies, covering areas like biotech and real estate. Some of the top buy recommendations include MicroStrategy, CorMedix, Hewlett Packard Enterprise, and Vertex Pharmaceuticals, among others. Readers are invited to interact with the new analysts, discuss their selections, and participate in the conversation.
FAQ
- What is the primary business of Arch Capital?
- What is the ticker symbol for Arch Capital?
- Does Arch Capital pay dividends?
- What sector is Arch Capital in?
- What industry is Arch Capital in?
- What country is Arch Capital based in?
- When did Arch Capital go public?
- Is Arch Capital in the S&P 500?
- Is Arch Capital in the NASDAQ 100?
- Is Arch Capital in the Dow Jones?
- When was Arch Capital's last earnings report?
- When does Arch Capital report earnings?
- Should I buy Arch Capital stock now?